title: In response.
authors.affiliation: Department of Anesthesiology and Perioperative Care, Toho University Ohashi Medical Center, Tokyo, Japan, ykotake@med.toho-u.ac.jp Department of Anesthesia, Nihon University School of Medicine, Tokyo, Japan Department of Anesthesia, Tokyo Women's Medical University, Tokyo, Japan Department of Anesthesia, Keio University School of Medicine, Tokyo, Japan.
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Kotake
authors.forename: Takahiro
authors.initials: T
authors.lastname: Suzuki
authors.forename: Makoto
authors.initials: M
authors.lastname: Ozaki
authors.forename: Junzo
authors.initials: J
authors.lastname: Takeda
mesh_terms: D000732:Androstanols / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D018908:Muscle Weakness / Q000517:prevention & control*; D009388:Neostigmine / Q000627:therapeutic use*; D019148:Neuromuscular Blockade / Q000379:methods*; D009469:Neuromuscular Junction / Q000187:drug effects*; D061886:Neuromuscular Monitoring; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use*; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
chemical_list: D000732:Androstanols; D002800:Cholinesterase Inhibitors; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D009388:Neostigmine